1. Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine
- Author
-
Myriam Robard, Daniel Pouliquen, Philippe Hulin, Vanessa Le Martelot, Marc Grégoire, Joëlle S. Nader, Jean-François Fonteneau, David Roulois, Charly Liddell, Sophie Deshayes, Christophe Blanquart, Marie-Noëlle Guilly, Amal Ouacher, Bernardo, Elizabeth, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), Laboratoire de Cancérologie Expérimentale (LCE), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Plateforme MicroPicel, Université de Nantes (UN), The research leading to these results has received funding from the National Health and Medical Research Institute (Inserm), the 'Fondation pour la Recherche Médicale' (FRM), the 'Ligue contre le Cancer' (Ligue Nationale and the Ligue inter-régionale du Grand Ouest, and comités 49, 56, 85), the 'Institut de Recherche en Santé Respiratoire des Pays de la Loire' (IRSR PdL), the 'Région Pays de la Loire', and the ARSMESO44 association.
- Subjects
0301 basic medicine ,Pathology ,Lung Neoplasms ,Epithelium ,Malignant transformation ,DNA Methyltransferase 3A ,Mixed Function Oxygenases ,0302 clinical medicine ,CDKN2A ,Cell Movement ,Mesothelioma ,DNA (Cytosine-5-)-Methyltransferases ,TETs ,Asbestos, Crocidolite ,preneoplastic mesothelial cells ,DNMTs ,3. Good health ,Cell Transformation, Neoplastic ,Oncology ,030220 oncology & carcinogenesis ,mesothelioma ,5-Methylcytosine ,Immunohistochemistry ,Epithelioid cell ,Research Paper ,medicine.medical_specialty ,Karyotype ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Biology ,03 medical and health sciences ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Cell Line, Tumor ,Proto-Oncogene Proteins ,medicine ,Biomarkers, Tumor ,Animals ,Cyclin-Dependent Kinase Inhibitor p18 ,Humans ,Cyclin-Dependent Kinase Inhibitor p16 ,Cell Proliferation ,Cell growth ,Mesothelioma, Malignant ,Epithelial Cells ,medicine.disease ,Rats, Inbred F344 ,Rats ,030104 developmental biology ,Cell culture ,Rat ,Precancerous Conditions ,Mesothelial Cell - Abstract
International audience; Malignant mesothelioma (MM) is one of the worst cancers in terms of clinical outcome, urging the need to establish and characterize new preclinical tools for investigation of the tumorigenic process, improvement of early diagnosis and evaluation of new therapeutic strategies. For these purposes, we characterized a collection of 27 cell lines established from F344 rats, after 136 to 415 days of induction with crocidolite asbestos administered intraperitoneally. Four mesotheliomas were distinguished from 23 preneoplastic mesothelial cell lines (PN) according to their propensity to generate tumors after orthotopic transplantation into syngeneic rats, their growth pattern, and the expression profile of three genes. PN cell lines were further discriminated into groups / subgroups according to morphology in culture and the expression profiles of 14 additional genes. This approach was completed by analysis of positive and negative immunohistochemical MM markers in the four tumors, of karyotype alterations in the most aggressive MM cell line in comparison with a PN epithelioid cell line, and of human normal mesothelial and mesothelioma cells and a tissue array. Our results showed that both the rat and human MM cell lines shared in common a dramatic decrease in the relative expression of Cdkn2a and of epigenetic regulators, in comparison with PN and normal human mesothelial cells, respectively. In particular, we identified the involvement of the relative expression of the Ten-Eleven Translocation (TET) family of dioxygenases and Dnmt3a in relation to the 5-hydroxymethylcytosine level in malignant transformation and the acquisition of metastatic potential. INTRODUCTION Malignant mesothelioma (MM) is a rare, aggressive cancer mainly related to asbestos exposure [1], the long latency time between exposure and occurrence of clinical symptoms limiting the efficacy of therapeutic interventions. Given its chemoresistance, current therapies have a negligible impact on overall survival due to a lack of understanding of the complex biology of MM [2]. Thus, a better understanding of the different steps in the development of this disease should be of great interest for the identification of early markers of MM AU 1
- Published
- 2016